A proteomic signature for dementia with Lewy bodies

A proteomic signature for dementia with Lewy bodies

Abstract Introduction We sought to determine if a proteomic profile approach developed to detect Alzheimer's disease would distinguish patients with Lewy body disease from normal controls, and if it would distinguish dementia with Lewy bodies (DLB) from Parkinson's disease (PD). Methods St...

Full description

Bibliographic Details
Main Authors: Sid E. O'Bryant, Tanis J. Ferman, Fan Zhang, James Hall, Otto Pedraza, Zbigniew K. Wszolek, Tori Como, David Julovich, Sravan Mattevada, Leigh A. Johnson, Melissa Edwards, Neill R. Graff‐Radford
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Dementia with Lewy bodies
Parkinson's disease
Proteomics
Blood biomarkers
Biomarker screening
Detection
Online Access:https://doi.org/10.1016/j.dadm.2019.01.006

Internet

https://doi.org/10.1016/j.dadm.2019.01.006

Similar Items